Summary of Purpose
Stroke is a leading causes of death and disability. At least 20% of strokes occur during sleep, so- called 'wake up stroke'. Thrombolysis with the clot-busting drug alteplase is effective for acute ischaemic stroke, provided that it is given within 4.5 hours of symptom onset. Patients with wake-up stroke are currently ineligible for clot-busting therapy. Previous studies indicate that many wake-up strokes occur...Read More →
The following dates are available for this trial. Trial information last updated on 22 February 2018.
|12 Jun 2017||6 Jun 2017||31 Dec 2019||31 Dec 2022||1 Apr 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Sponsors See All